Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
PROCTER & GAMBLE HEALTH TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
TEVA PHARMA Dec-13 |
PROCTER & GAMBLE HEALTH/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 3,486 | - | |
Low | Rs | 3,883 | 3,028 | - | |
Sales per share (Unadj.) | Rs | 740.7 | 2,000.5 | - | |
Earnings per share (Unadj.) | Rs | 138.2 | 125.0 | - | |
Cash flow per share (Unadj.) | Rs | 155.2 | 286.7 | - | |
Dividends per share (Unadj.) | Rs | 95.00 | 109.40 | - | |
Avg Dividend yield | % | 2.1 | 3.4 | 61.2% | |
Book value per share (Unadj.) | Rs | 447.6 | 2,222.2 | - | |
Shares outstanding (eoy) | m | 16.60 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.6 | 383.4% | |
Avg P/E ratio | x | 33.5 | 26.1 | 128.4% | |
P/CF ratio (eoy) | x | 29.8 | 11.4 | 262.3% | |
Price / Book Value ratio | x | 10.3 | 1.5 | 704.8% | |
Dividend payout | % | 68.7 | 87.5 | 78.5% | |
Avg Mkt Cap | Rs m | 76,761 | 2,761,843 | 2.8% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 2,062 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,744.4 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,696,422 | 0.7% | |
Other income | Rs m | 184 | 0 | - | |
Total revenues | Rs m | 12,480 | 1,696,422 | 0.7% | |
Gross profit | Rs m | 3,247 | 464,566 | 0.7% | |
Depreciation | Rs m | 281 | 137,123 | 0.2% | |
Interest | Rs m | 8 | 33,320 | 0.0% | |
Profit before tax | Rs m | 3,142 | 294,122 | 1.1% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,075 | -0.0% | |
Tax | Rs m | 847 | -3,591 | -23.6% | |
Profit after tax | Rs m | 2,295 | 105,974 | 2.2% | |
Gross profit margin | % | 26.4 | 27.4 | 96.4% | |
Effective tax rate | % | 27.0 | -1.2 | -2,208.8% | |
Net profit margin | % | 18.7 | 6.2 | 298.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,145,757 | 1.0% | |
Current liabilities | Rs m | 6,791 | 999,197 | 0.7% | |
Net working cap to sales | % | 40.0 | 8.6 | 463.3% | |
Current ratio | x | 1.7 | 1.1 | 150.4% | |
Inventory Days | Days | 263 | 91 | 289.4% | |
Debtors Days | Days | 343 | 96 | 358.1% | |
Net fixed assets | Rs m | 10,617 | 554,089 | 1.9% | |
Share capital | Rs m | 166 | 4,176 | 4.0% | |
Net worth | Rs m | 7,431 | 1,884,403 | 0.4% | |
Long term debt | Rs m | 0 | 867,418 | 0.0% | |
Total assets | Rs m | 22,330 | 3,876,868 | 0.6% | |
Interest coverage | x | 409.1 | 9.8 | 4,162.5% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 125.8% | |
Return on assets | % | 10.3 | 3.6 | 287.0% | |
Return on equity | % | 30.9 | 5.6 | 549.1% | |
Return on capital | % | 42.4 | 4.9 | 859.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 270,322 | 0.9% | |
From Investments | Rs m | -215 | -95,786 | 0.2% | |
From Financial Activity | Rs m | -985 | -324,269 | 0.3% | |
Net Cashflow | Rs m | 1,160 | -149,733 | -0.8% |
Compare PROCTER & GAMBLE HEALTH With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare PROCTER & GAMBLE HEALTH With: PHARMAIDS PH KIMIA BIOSCIENCES ELDER PHARMA MESCO PHARMA TYCHE INDUSTRIES
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.